Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

盘后复发的概率和决定因素ontinuation of inhaled corticosteroids in patients with COPD treated in general practice

Abstract

Objective:

The objective of the study was to assess the probability, and explore determinants of adverse respiratory outcome after discontinuation of inhaled corticosteroid (ICS) treatment in subjects with chronic obstructive pulmonary disease (COPD) diagnosed and treated in general practice.

Design:

Prospective unblinded ICS withdrawal study.

Subjects:

201 ICS treated COPD patients with various degrees of airflow limitation from 45 Dutch general practices.

Main outcome measures:

Probability of and time to exacerbation or unremitting worsening of respiratory symptoms after ICS discontinuation.

Results:

Mean age was 60.6 (S.D. 9.5) years, post-bronchodilator forced expiratory volume in 1s (FEV1) 65.6 (S.D. 15.7) % predicted. Overall probability of adverse respiratory outcome after ICS discontinuation was 0.37 (95% confidence interval (CI) 0.31, 0.44). Survival analysis showed that age, gender, smoking status and reversibility of airflow limitation were independent predictors of adverse respiratory outcome. For females, the adjusted hazard ratio was 2.14 (95% CI 1.31, 3.50) compared to males. For age, the hazard ratio was 1.05 (95% CI 1.02, 1.08) per year lived.

Conclusion:

Discontinuation of inhaled corticosteroids may harm patients with COPD. The probability of an adverse respiratory outcome may be higher in women, elderly patients, smokers and patients with higher bronchodilator reversibility while on inhaled steroid treatment.

Author information

Affiliations

Authors

Corresponding author

Correspondence toT.R.J. Schermer.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Schermer, T., Hendriks, A., Chavannes, N.et al.盘后复发的概率和决定因素ontinuation of inhaled corticosteroids in patients with COPD treated in general practice.Prim Care Respir J13,48–55 (2004). https://doi.org/10.1016/j.pcrj.2003.11.005

Download citation

  • Issue Date:

  • DOI:https://doi.org/10.1016/j.pcrj.2003.11.005

Further reading

Search

Quick links

Nature Briefing

Sign up for theNature Briefingnewsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing